Monday, January 13, 2014 - The Onder Law Firm, the prominent national pharmaceutical and medical device law firm, is offering no-obligation baby powder ovarian cancer attorney consultation at no cost to men who have lost a loved one to ovarian cancer that may be traced to talcum powder use. Baby powder, when used for perineal hygiene, has been found to increase a woman‘s risk of developing ovarian cancer by 33%. Dr. Daniel Cramer, a Harvard epidemiologist, testified in the first talcum powder cancer lawsuit that based on thirty years of research, he believes perineal talcum powder use can be blamed for 10,000 cases of ovarian cancer each year.
Talc, which is the active ingredient in baby powder, can enter the female reproductive system when applied to the perineal area either through direct dusting or through the use of feminine products such as tampons, sanitary pads, and diaphragms that have been dusted with talcum powder. Researchers have found that talc particles that reach the ovaries may remain there for years without disintegrating, causing inflammation and creating an environment that is conducive to the growth of cancerous cells. Women who have used talc-based baby powder and other feminine hygiene products frequently or daily for a long duration (20 or more years) are most at risk of developing ovarian cancer.
The first baby powder cancer lawsuit was won against talcum powder producer Johnson & Johnson in October of 2013. A South Dakota federal jury found that the plaintiff‘s ovarian cancer was connected to her regular use of talcum powder products, including Johnson & Johnson‘s Shower to Shower, over the course of decades. Upon winning the case, the plaintiff‘s lawyer, Greg Eiesland, proclaimed, ‘‘This is an absolutely great day for women all over the country. The jury wanted this connection out there in the public. They can‘t hide this anymore.‘‘ A lawyer representing Johnson & Johnson stated during the trial that the company knew of the research proving a baby powder ovarian cancer risk but deemed the danger insignificant and unproven. The American Cancer Society estimates that approximately 14,000 women died as a result of ovarian cancer during 2013.
Johnson & Johnson has made no official comment following the outcome of this trial. On October 15, shortly after the baby powder lawsuit trial concluded, Johnson & Johnson announced third quarter earnings for 2013 at $17.6 billion. This sum represents a 3.1% increase over the previous year‘s third quarter.
The baby powder cancer lawyers at The Onder Law Firm are investigating cases in which talcum powder users were diagnosed with or died as a result of ovarian cancer. The talcum powder lawyers at the firm believe these women and their family members may be entitled to real compensation for damages and loss suffered as a result of the disease. The husbands, sons, and other close family members of women who died as a result of ovarian cancer after using baby powder may receive a free, no-obligation consultation with a talcum powder cancer attorney by visiting the firm‘s baby powder ovarian cancer website. The Onder Law Firm welcomes baby powder and talcum powder cancer lawsuit inquiries from law firms in regards to handling them or working as co-counsel.